Skip to content

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children

Evaluation of Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children With Early Childhood Caries.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04958005
Enrollment
58
Registered
2021-07-12
Start date
2021-07-01
Completion date
2021-09-30
Last updated
2021-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Childhood Caries

Keywords

early childhood caries

Brief summary

This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.

Detailed description

Fifty six children ( 28 with early childhood caries and 28 without early childhood caries ; age range 3-6 years) will be recruited for the study. Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be recorded and saliva samples will be collected. Interleukin-32, Interleukin-10, Interleukin-6 and TNF-α will be analyzed in saliva samples by ELISA.

Interventions

DIAGNOSTIC_TESTELISA

Enzim linked immunoabsorbant assay

Sponsors

Aydin Adnan Menderes University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to 70 Months

Inclusion criteria

* Children with untreated early chilhood caries * Age between 3 and 6 years

Exclusion criteria

* Having a systemic problem or mental retardation * Children with treated caries

Design outcomes

Primary

MeasureTime frameDescription
IL-32BaselineInterleukin- 32 level
IL-10BaselineInterleukin- 10 level

Secondary

MeasureTime frameDescription
IL-6BaselineInterleukin- 6 level
Tnf-AlphaBaselineTnf-alpha level

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026